Content about Branded

January 17, 2013

The Food and Drug Administration on Wednesday approved Protein Sciences' Flublok, the first trivalent influenza vaccine made using an insect virus (baculovirus) expression system and recombinant DNA technology.

SILVER SPRING, Md. — The Food and Drug Administration on Wednesday approved Protein Sciences' Flublok, the first trivalent influenza vaccine made using an insect virus (baculovirus) expression system and recombinant DNA technology. 

January 17, 2013

The Food and Drug Administraiton has approved a drug for replacing clotting proteins in the blood for conditions in which patients have too little of them.

SILVER SPRING, Md. — The Food and Drug Administraiton has approved a treatment for replacing clotting proteins in the blood for conditions in which patients have too little of them.

The FDA announced the approval of Octapharma's Octaplas, a sterile, frozen solution of pooled human plasma from multiple donors that has been treated with a solvent detergent process.

January 17, 2013

More than 5,000 medicines are under development, of which 70% are potentially the first of their class, according to a new report.

WASHINGTON — More than 5,000 medicines are under development, of which 70% are potentially the first of their class, according to a new report.

January 17, 2013

Fortune magazine has released its list of the 100 best companies to work for this year, and a number of retailers and suppliers made the cut.

NEW YORK — Fortune magazine has released its list of the 100 best companies to work for this year, and a number of retailers and suppliers made the cut.

Among retailers, Wegman's Food Markets came in at fifth place, with 8.3% job growth. Nugget Market, a supermarket chain based in Sacramento, Calif., ranked 37th; Whole Foods ranked 71st; and Publix Super Markets ranked 77th.

Among suppliers, Millennium: The Takeda Oncology Company, ranked 20th; Genentech ranked 36th; and Novo Nordisk ranked 48th. Confectionary manufacturer Mars ranked 95th.

January 16, 2013

The Food and Drug Administration has approved an ulcerative colitis drug made by Santarus, the drug maker said.

SAN DIEGO — The Food and Drug Administration has approved an ulcerative colitis drug made by Santarus, the drug maker said.

Santarus announced the approval of Uceris (budesonide) extended-release tablets for mild to active UC. The company plans to launch the drug in March.

January 16, 2013

New York is hoping to battle the theft of highly addictive prescription drugs, such as Oxycontin, by stocking pharmacies with fake pill bottles that are fitted with GPS tracking devices, according to published reports.

NEW YORK — New York is hoping to battle the theft of highly addictive prescription drugs, such as Oxycontin, by stocking pharmacies with fake pill bottles that are fitted with GPS tracking devices, according to published reports.

The Washington Post reported that Police Commissioner Raymond Kelly said, in prepared remarks provided before a conference Tuesday in California sponsored by former president Bill Clinton’s foundation, that the initiative was sparked by a series of crimes associated with the black market for prescription painkillers.

January 16, 2013

Safeway on Wednesday shipped an additional 200,000 doses of flu vaccine to its pharmacies in the U.S.

PLEASANTON, Calif. — Safeway on Wednesday shipped an additional 200,000 doses of flu vaccine to its pharmacies in the U.S.

"This additional quantity of flu vaccine will allow us to meet the needs of our customers to help them remain healthy this season," stated Darren Singer, SVP Pharmacy. "Our pharmacists administer the vaccine on a walk-in basis. The process is simple, convenient and affordable. We want all of our customers to have this protection."

January 15, 2013

The state supreme court in Alabama ruled that brand-name drug companies could be sued if patients suffer complications from generic versions of their medicines, according to published reports.

NEW YORK — The state supreme court in Alabama ruled that brand-name drug companies could be sued if patients suffer complications from generic versions of their medicines, according to published reports.

According to The New York Times, an Alabama man named Danny Weeks claimed he developed tardive dyskinesia after taking generic versions of Pfizer's acid reflux drug Reglan (metoclopramide). Pfizer acquired rights to the drug when it bought Wyeth in 2009, and generic drug makers Teva and Actavis, now owned by Watson, make generic versions.

January 15, 2013

Drug maker Otsuka Pharmaceuticals can keep generic versions of its schizophrenia drug off the market, according to published reports.

NEW YORK — Drug maker Otsuka Pharmaceuticals can keep generic versions of its schizophrenia drug off the market, according to published reports.

Bloomberg reported that the Supreme Court upheld a ruling that allowed Otsuka to block Canadian generic drug maker Apotex from marketing a version of the antipsychotic Abilify (aripiprazole), which Otsuka co-markets with Bristol-Myers Squibb.

January 15, 2013

A maker of drugs for epilepsy has appointed a new executive.

ROCKVILLE, Md. — A maker of drugs for epilepsy has appointed a new executive.

Supernus Pharmaceuticals announced the appointment of Victor Vaughn as SVP sales, a position in which he will be responsible for leading all the company's sales activities.

January 15, 2013

While replacing a single combination pill for HIV with generics would save the healthcare system money, it could also diminish the effectiveness of treatment, a new study suggests.

NEW YORK — While replacing a single combination pill for HIV with generics would save the healthcare system money, it could also diminish the effectiveness of treatment, a new study suggests.

The study, led by investigators at the Massachusetts General Hospital and Weill Cornell Medical College, and published in the Jan. 15 issue of Annals of Internal Medicine, found $1 billion in potential savings, but the more complicated treatment regimen might result in more patients missing doses and a loss of drug effectiveness.

January 15, 2013

Symphony Health Solutions named Frank Lavelle CEO.

HORSHAM, Pa. — Symphony Health Solutions on Tuesday named Frank Lavelle CEO.  

January 15, 2013

A drug-security product has won a drug-abuse prevention award.

LINCOLN, Calif. — A drug-security product has won a drug-abuse prevention award.

The Locking Cap was named as one of the "Top 5 Technologies to Reduce Prescription Drug Abuse" by the Center for Lawful Access and Abuse Deterrence.

The cap is a four-digit combination-locking lid for prescription medication bottles. The maker of the cap, Cap-n-Lock, launched an updated version of the cap at the beginning of the year to attract the attention of shoppers.

January 15, 2013

The nation’s highest court has agreed to hear three cases stemming from the longstanding but controversial practice by which branded and generic drug makers agree to delay introduction of a me-too medicine as its brand-name counterpart nears the end of its patent protection.

The nation’s highest court has agreed to hear three cases stemming from the longstanding but controversial practice by which branded and generic drug makers agree to delay introduction of a me-too medicine as its brand-name counterpart nears the end of its patent protection. A ruling by the Supreme Court could alter the delicate balance sometimes struck between the two industries as they scramble to either delay or hasten the onset of generic competition for big-selling, patented drugs.

January 14, 2013

The worst of the flu season may be over, at least for those on the East Coast. In a late morning press conference with reporters on Friday, Thomas Frieden, director of the Centers for Disease Control and Prevention, said, "We are seeing a decrease in some regions."

Just don't tell that to anyone living in New York or Boston or Chicago, at least not before slipping on a facemask first.

ATLANTA — The worst of the flu season may be over, at least for those on the East Coast. In a late morning press conference with reporters on Friday, Thomas Frieden, director of the Centers for Disease Control and Prevention, said, "We are seeing a decrease in some regions." 

Just don't tell that to anyone living in New York, Boston or Chicago, at least not before slipping on a facemask first.  

January 14, 2013

Amid an unusually strong flu season that the Centers for Disease Control and Prevention has called an epidemic, supplies of flu vaccines are running low, and some people hoping to get immunized are having trouble finding them.

Amid an unusually strong flu season that the Centers for Disease Control and Prevention has called an epidemic, supplies of flu vaccines are running low, and some people hoping to get immunized are having trouble finding them.

January 14, 2013

Jewel-Osco is shipping "thousands" of extra doses of flu vaccine amid a flu season that the Centers for Disease Control and Prevention has labeled an epidemic, the retail chain said.

ITASCA, Ill. — Jewel-Osco is shipping "thousands" of extra doses of flu vaccine amid a flu season that the Centers for Disease Control and Prevention has labeled an epidemic, the retail chain said.

The company plans to ship 7,000 doses to its pharmacies starting Tuesday and continuing into Wednesday, with about 170 pharmacies set to receive some of the doses.

January 14, 2013

According to a new study by researchers at Wake Forest Baptist Medical Center released Thursday, less than 45% of children were vaccinated against the flu during a five-year study period.

WINSTON-SALEM, N.C. — According to a new study by researchers at Wake Forest Baptist Medical Center released Thursday, less than 45% of children were vaccinated against the flu during a five-year study period.

January 14, 2013

Medagate, a wholly owned subsidiary of InComm Holdings, announced the launch of the MasterCard Dual Value Health Card, the first dual network healthcare spending card.

ATLANTA — Medagate, a wholly owned subsidiary of InComm Holdings, on Monday announced the launch of the MasterCard Dual Value Health Card, the first dual network healthcare spending card. The Dual Value Health Card enables employers and health plans to combine a member/employee healthcare funding purse with a restricted-spend purse for targeted items and incentives.

January 14, 2013

A new drug for treating attention deficit hyperactivity disorder made by Pfizer is now available, the drug maker said.

NEW YORK — A new drug for treating attention deficit hyperactivity disorder made by Pfizer is now available, the drug maker said.

Pfizer announced the availability of Quillivant XR (methylphenidate hydrochloride) extended-release oral suspension, calling it the first once-per-day, extended-release liquid formulation of methylphenidate. The Food and Drug Administration approved the drug in September 2012.

January 14, 2013

Egg allergies may no longer be a valid reason to not get a flu shot, the American College of Allergy, Asthma and Immunology announced Friday.

ARLINGTON HEIGHTS, Ill. — Egg allergies may no longer be a valid reason to not get a flu shot, the American College of Allergy, Asthma and Immunology announced Friday. 

January 14, 2013

As if the reported spot shortages of flu vaccine aren't bad enough, there have been reports of similar shortages of flu drugs throughout the United States and parts of Canada due to increased demand.

As if the reported spot shortages of flu vaccine aren't bad enough, there have been reports of similar shortages of flu drugs throughout the United States and parts of Canada due to increased demand.

January 11, 2013

The worst of the flu season may be over, at least for those in the South.

ATLANTA — The worst of the flu season may be over, at least for those in the South. In a late morning press conference with reporters, Thomas Frieden, director of the Centers for Disease Control and Prevention, said, "We are seeing a decrease in some regions."

January 11, 2013

Growth in the consumer products market is likely to slow down over the next five years, while pharmacy retailers will see a profit windfall due to the generic drug cycle, according to a new report.

NEW YORK -- Growth in the consumer products market is likely to slow down over the next five years, while pharmacy retailers will see a profit windfall due to the generic drug cycle, according to a new report.

January 11, 2013

A panel of Food and Drug Administration experts has recommended approval for an experimental Type 2 diabetes drug made by Johnson & Johnson, the drug maker said.

RARITAN, N.J. -- A panel of Food and Drug Administration experts has recommended approval for an experimental Type 2 diabetes drug made by Johnson & Johnson, the drug maker said.

J&J said the FDA's Endocrinologic and Metabolic Drugs Advisory Committee had recommended approval for canagliflozin, which the company plans to market under the name brand Invokana. The FDA is not required to follow the votes of advisory committees when deciding whether or not to approve a drug, but usually does.